Harald Holte Selected Research

Harald Holte Research Topics

Disease

42	Lymphoma (Lymphomas) 04/2024 - 02/2002
25	Neoplasms (Cancer) 04/2024 - 06/2002
19	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 06/2002
15	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 11/2006
15	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 02/2002
10	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 04/2010
7	Disease Progression 10/2021 - 06/2007
7	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 01/2005
6	Fatigue 01/2021 - 09/2005
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 01/2017
5	Pathologic Complete Response 04/2013 - 01/2006
4	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2010 - 02/2002
3	Heart Failure 03/2016 - 05/2003
3	Febrile Neutropenia 04/2012 - 04/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 05/2014
2	Plasmacytoma 02/2018 - 12/2015
2	Multiple Myeloma 02/2018 - 12/2015
2	Second Primary Neoplasms (Neoplasms, Second) 01/2017 - 01/2016
2	Carcinoma (Carcinomatosis) 12/2015 - 12/2004
2	Infections 06/2010 - 05/2003
1	Inflammation (Inflammations) 04/2024
1	Residual Neoplasm 01/2022
1	Overweight 05/2019
1	Cytokine Release Syndrome 01/2019
1	Obesity 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Leukemia 05/2017
1	Cardiotoxicity 01/2016
1	Left Ventricular Dysfunction 08/2015
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2015
1	Hypothyroidism 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2012

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 10/2023 - 11/2006
6	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2005
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2013
5	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 05/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2003
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 05/2003
5	tisagenlecleucelIBA 01/2022 - 01/2019
5	Messenger RNA (mRNA)IBA 12/2017 - 02/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2023 - 05/2003
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
4	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2017
4	RadiumIBA 12/2009 - 09/2005
3	AminoglycosidesIBA 04/2012 - 04/2007
3	Penicillin G (Benzylpenicillin)FDA LinkGeneric 04/2012 - 04/2007
2	AnthracyclinesIBA 03/2016 - 01/2016
2	InterferonsIBA 01/2015 - 01/2013
2	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2015 - 12/2009
2	Gonadal HormonesIBA 01/2015 - 12/2009
2	EnzymesIBA 10/2013 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 06/2002
2	Penicillins (Penicillin)FDA Link 04/2012 - 12/2008
2	Hormones (Hormone)IBA 12/2009 - 12/2004
2	Cyclin D1IBA 06/2007 - 02/2003
1	Blood Proteins (Serum Proteins)IBA 04/2024
1	Circulating Tumor DNAIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	Bendamustine Hydrochloride FDA Link 10/2023
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Granzymes (Granzyme)IBA 01/2021
1	Brentuximab VedotinIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	LigandsIBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	CD19 AntigensIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Contrast MediaIBA 07/2018
1	MicroRNAs (MicroRNA)IBA 12/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2017
1	Mitogen-Activated Protein KinasesIBA 12/2017
1	ParaffinIBA 05/2017
1	Formaldehyde (Formol)FDA Link 05/2017
1	coltuximab ravtansineIBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 01/2016
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2015
1	AntigensIBA 02/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2015
1	Thyroid HormonesIBA 01/2015
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012
1	InterleukinsIBA 10/2012
1	Interleukin-10 (Interleukin 10)IBA 10/2012

Therapy/Procedure

33	Therapeutics 11/2022 - 02/2002
26	Drug Therapy (Chemotherapy) 10/2021 - 02/2002
14	Stem Cell Transplantation 10/2021 - 09/2012
14	Radiotherapy 01/2020 - 12/2004
5	Hematopoietic Stem Cell Transplantation 05/2019 - 08/2015
4	Aftercare (After-Treatment) 05/2017 - 09/2005
2	Radioimmunotherapy 01/2020 - 01/2017
2	Immunotherapy 10/2019 - 01/2015
2	Induction Chemotherapy 05/2014 - 05/2003
2	Transplantation 01/2013 - 09/2012
2	Remission Induction 06/2010 - 11/2006
2	Complementary Therapies (Alternative Medicine) 12/2004 - 11/2003
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2018
1	Injections 01/2015
1	Combined Modality Therapy 05/2014